Regulatory B Cells-Immunopathological and Prognostic Potential in Humans

• Published in: Cells (Basel, Switzerland) Switzerland), 2024-02, Vol.13 (4), p.357
• Main Authors: Veh, Johanna, Ludwig, Carolin, Schrezenmeier, Hubert, Jahrsdörfer, Bernd
• Format: Article
• Language: English
• Subjects: Adenosine; Antigens; Autoimmune diseases; B cells; CD1d antigen; CD25 antigen; CD73 antigen; Cell surface; Cytokines; Dendritic cells; Enzymes; GraB cell; Graft rejection; Graft-versus-host reaction; Granzyme B; Growth factors; Health aspects; Homeostasis; Immune response; Immunological tolerance; immunosuppression; Inflammation; Inflammatory bowel disease; Interleukin 10; Ligands; Lymphocytes; Lymphocytes B; Metabolic disorders; PD-L1 protein; Regulation; regulatory B cell; T cell receptors; Transforming growth factor-b; Tumor necrosis factor-TNF
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells13040357

The aim of the following review is to shed light on the putative role of regulatory B cells (Bregs) in various diseases and highlight their potential prognostic and therapeutic relevance in humans. Regulatory B cells are a heterogeneous group of B lymphocytes capable of suppressing inflammatory immune reactions. In this way, Bregs contribute to the maintenance of tolerance and immune homeostasis by limiting ongoing immune reactions temporally and spatially. Bregs play an important role in attenuating pathological inflammatory reactions that can be associated with transplant rejection, graft-versus-host disease, autoimmune diseases and allergies but also with infectious, neoplastic and metabolic diseases. Early studies of Bregs identified IL-10 as an important functional molecule, so the IL-10-secreting murine B10 cell is still considered a prototype Breg, and IL-10 has long been central to the search for human Breg equivalents. However, over the past two decades, other molecules that may contribute to the immunosuppressive function of Bregs have been discovered, some of which are only present in human Bregs. This expanded arsenal includes several anti-inflammatory cytokines, such as IL-35 and TGF-β, but also enzymes such as CD39/CD73, granzyme B and IDO as well as cell surface proteins including PD-L1, CD1d and CD25. In summary, the present review illustrates in a concise and comprehensive manner that although human Bregs share common functional immunosuppressive features leading to a prominent role in various human immunpathologies, they are composed of a pool of different B cell types with rather heterogeneous phenotypic and transcriptional properties.